CompletedPhase 1/2

The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome

Iraq14 participantsStarted 2024-03-12

Plain-language summary

The objective of this study was to assess the efficacy of Botulinum toxin type (A) (BoNTA) injection in Myofascial pain syndrome management in the terms of duration of function improvement and pain reduction. Material and methods: Fourteen patients with Myofascial pain syndrome related to masticatory muscles were presented with trismus, pain and impairment of oral function. Treatment plan was established by utilizing thirty units of Botulinum toxin type (A) which was injected into masseter and sometimes temporalis muscle.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient with myofascial pain related to the muscles of mastication (masseter and temporalis muscle).
✓. Patient with regional pain.
✓. Patient with or without limited mouth opening (trismus).
✓. Presence of trigger points within the identified masticatory muscles.

What they're measuring

Pain level

Timeframe: 16 weeks

Trial details

NCT IDNCT06824324

SponsorYassir R. Al-khannaq

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-04

View on ClinicalTrials.gov More Myofacial Pain Syndrome trials